gest that autism spectrum disorder (ASD) prevalence is reaching a peak. However, longitudinal data with follow-up into adulthood are needed to truly determine whether the prevalence has stabilized. We used competing-risks survival analysis 6 to estimate ASD age-specific cumulative incidence in 2-year birth cohorts using age as the underlying time scale; persons were followed up until ASD diagnosis, death, emigration, or December 31, 2016, whichever came first (SAS version 9.4; SAS Institute Inc). In sensitivity analysis, we recalculated cumulative incidence based on the second ASD diagnosis for all persons with an ini- Results | Autism spectrum disorder was reported for 31 961 persons among 2 055 928 live births. Each birth cohort cumulative incidence curve followed its own trajectory, with new case ascertainment into adulthood for older cohorts, and reaching a higher cumulative incidence with age than any of the earlier cohorts ( Figure) . (Table) . The Figure inset for 1994-2012 births reveals shifts in the age and rate at which the curve for a given birth cohort begins to ascend more steeply than previous cohorts, yielding a cumulative incidence at age 4 of 0.11% (95% CI, 0.02%-0.40%) in persons born in 1994-1995 vs 0.37% (95% CI, 0.13%-0.88%) for persons born in 2012 (Table) . In sensitivity analysis, the overall cumulative incidence pattern was unchanged but the maximum value declined (2.50% [95% CI, 2.29%-2.73%] at age 16 for persons born in 2000-2001).
Discussion | The Danish ASD trends are consistent with US crosssectional data for similar birth cohorts. [1] [2] [3] [4] [5] These populationwide data with follow-up into adulthood revealed no plateau in curves in more recent birth years, suggesting that ASD cumulative incidence has not stabilized. The ongoing increases at young ages in more recent cohorts suggest that future cumulative incidence could exceed 2.8%. The age shifts at which the curve for a given birth cohort ascended more steeply than previous cohorts and the associated increases in cumulative incidence at young ages suggest that the services that support early detection of ASD expanded during this study's observation period. However, new case ascertainment also continued well into adulthood in older cohorts. This ascertainment pattern likely reflects the complexity of the ASD phenotype, diverse age course of individual behavioral development, and family and community differences over time in ASD detection that can delay diagnosis into adulthood.
This study cannot delineate causes of the observed ASD trends or provide results by ASD characteristics that might aid services planning. Nevertheless, the results highlight the substantial public health challenges that lie ahead to meet the diverse support needs of persons with ASD across the life span. We extracted data for primary end points because RCTs are most often powered for these end points. The following data were extracted from each trial: P values for primary end points (excluding subgroups), study title, journal name, funding source, sample size, type of intervention, whether the end point was mortality, whether the trial was multicentered, and whether the trial was multinational. Data were extracted blinded and in duplicate. Discrepancies were resolved by consensus.
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We first determined the proportion of end points that would maintain statistical significance with a threshold of P less than .005 and that would be reclassified as suggestive 
